EIHSX Rating, Research - Eaton Vance Worldwide Health Sci I

Eaton Vance Worldwide Health Sci I (eihsx)

Last Updated by WikiWealth | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help
placeholder_summary.png

Asset Allocation (% of Port)

US Stocks
Non-US Stocks
Bonds
Cash
Other
%
%
%
%
%

Geographic Allocation (% of Port)

North America
Europe
Asia
South America
Africa
Australia + Pacific Islands
Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics

Strengths + Opportunities = 34

Threats + Weaknesses = 23

When strengths & opportunities substantially exceed threats & weaknesses an investment in the eihsx mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Eaton Vance Worldwide Health Sci I (EIHSX) Description: EIHSX is a mutual fund, which is an investment that owns a basket of assets. The EIHSX mutual fund was provided by Eaton Vance and this investment vehicle derives the majority of its value from equity holdings (stocks). Eaton Vances mutual fund has a long management tenure and is in the small fund size classification. EIHSXs minimum initial investment amount is $250000 while the IRA minimum is $0. EIHSXs expense ratio is roughly 2%. The latest EIHSXs front end load was 0% and the back end load was 0%. The Eaton Vance Worldwide Health Sci I (EIHSX) mutual fund falls under the health category. EIHSX focuses its investments in USA and EIHSX is focused on the health industry or fund sector. The Eaton Vance Worldwide Health Sci I (EIHSX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find EIHSXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of EIHSXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks long-term capital growth. The fund invests at least 80% of net assets in securities (primarily common stocks (see stock research)) of companies principally engaged in the discovery, development, production or distribution of products (or services) related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care, and medical equipment and supplies. It may invest in fixed-income securities of health sciences companies. The fund invests in foreign securities and normally invests in issuers located in at least three different countries.


Management Analysis Update


Performance Analysis Update